From Scientist to Analyst to Strategist: Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership in Multinational Pharma

By sjmartinez • January 18, 2025

Gal AR, Herrmann K, Czernin J. From Scientist to Analyst to Strategist: Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership in Multinational Pharma. J Nucl Med. 2025 Jan 16:jnumed.124.269177. doi: 10.2967/jnumed.124.269177. Epub ahead of print. PMID: 39819691.

Tags: Cardiology/Epi, Publications

Implementing a Cardiology Quality Incentive Program to Improve Guideline-Directed Medical Therapy

Cho DJ, Bokhoor PI, Dermenchyan A, Brownell N, Delavin NL, Furlong S, Hoo J, Tibbe T, Chen LY, Vangala S, Waterman BA, Han M, Fonarow[...]

Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy

Juarez Casillas JE, Nikitas J, Rettig MB, Reiter RE, Lee A, Steinberg ML, Valle L, Kalbasi TR, Calais J, Czernin J, Eala MA, Tsai S,[...]

Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials

Sharifan A, Fonarow G. Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials. Heart. 2025 Jun 20:heartjnl-2025-326515. doi: 10.1136/heartjnl-2025-326515. Epub ahead of[...]